Osteopontin is not Critical for Otoconia Formation or Balance Function by Zhao, Xing et al.
Osteopontin is not Critical for Otoconia Formation or Balance
Function
XING ZHAO1, SHERRI M. JONES2, WALLACE B. THORESON3, AND YUNXIA WANG LUNDBERG1,
1Genetics Department, Boys Town National Research Hospital, Omaha, NE 68131, USA
2Department of Communication Sciences and Disorders, College of Allied Health Sciences East Carolina University, Greenville,
NC 27858, USA
3Department of Ophthalmology and Visual Sciences, University of Nebraska Medical Center, Omaha, NE 68198, USA
Received: 21 September 2007; Accepted: 29 February 2008; Online publication: 6 May 2008
ABSTRACT
Unlike the structural and mechanical role of bone
crystals, the inertial mass of otoconia crystals provides
a shearing force to stimulate the mechanoreceptors of
the utricle and saccule (the gravity receptor organ)
under the stimuli of linear motion. It is not clear
whether otoconia, composed primarily of CaCO3 and
glycoproteins, go through similar calcification pro-
cesses as bone. We have recently shown that otoconin-
90 (Oc90) regulates the growth of otoconia crystals as
osteopontin does bone crystals. Here, we analyzed the
role of this non-collagenous bone matrix protein,
osteopontin, in otoconia formation and balance
function utilizing its knockout mice, whose inner ear
phenotype has not been examined. Despite the
presence of the protein in wild-type otoconia and
vestibular hair cells, morphological, ultrastructural,
and protein and calcium composition analyses of
osteopontin null otoconia show that the protein is
not needed for crystal formation, and no evidence of
compensatory protein deposition is found. Employ-
ment of a wide spectrum of balance behavioral tests
demonstrates that the protein is not critical for
balance function either, which is confirmed by the
normal function of the gravity receptor organ directly
measured with linear vestibular-evoked potentials
(VsEPs). When compared with findings on other
otoconins, the data manifest a hierarchy of impor-
tance of proteins in crystallization and indicate
mechanistic similarities and differences between bone
and otoconia calcification.
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INTRODUCTION
In humans, otoconia and other vestibular disorders
are prevalent and severely interfere with daily life. It is
estimated that 50% of those at age 65 years or older
will develop positional vertigo, whose most common
cause is otoconia dislocation. Otoconia degeneration
and abnormalities worsen with exposure to ototoxic
drugs, infection of the vestibular labyrinth, certain
genetic mutations, and in the elderly (Preston et al.
1975; Ross et al. 1976; Lim 1984; Zhang et al. 1996;
Balsamo et al. 2000), although accurate statistics are not
available. To develop effective treatments, it is impera-
tive to identify the necessary and sufficient components
for crystal regeneration or prevention of degeneration.
We have recently demonstrated that, during the
formative stage, otoconia matrix particles (the organic
framework upon which inorganic CaCO3 crystals are
deposited) and crystals exhibit a striking ultrastruc-
tural resemblance to bone matrix vesicles and crystals,
respectively, (Zhao et al. 2007) despite the fact that
bone crystals contain calcium phosphate (apatite),
and otoconia crystals contain calcium carbonate
(calcite). Furthermore, the organic components of
otoconia are either the same or belong to the same
family of bone matrix proteins. Both types of matrices
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contain sulfated glycosaminoglycans (as GAGs or
proteoglycans), osteopontin (OPN), fetuin-A, and
members of the collagen X family (collagen X in
bone and otolin in otoconia; Lundberg et al. 2006;
Zhao et al. 2007). The fourth known otoconia
component protein, Oc90, is the predominant otoco-
nial matrix protein (Wang et al. 1998; Verpy et al.
1999) whose role in bone formation has yet to be
studied.
Of the few otoconial proteins that are also present
in bone, OPN is a non-collagenous bone matrix
protein involved in ossification. Similar to the essen-
tial role of Oc90 in forming the otoconia matrix and
regulating crystal growth (Zhao et al. 2007), OPN
limits bone crystal sizes and mineral content (Boskey
et al. 1993; Hunter et al. 1994; Shapses et al. 2003). In
the vestibule, OPN is detected in otoconia and
expressed in vestibular hair cells, dark cells, and the
endolymph sac (Takemura et al. 1994; Sakagami
2000). The gene is expressed in a number of nervous
tissues including the hindbrain, cerebellum, brain-
stem, spinal cord, and some parts of the peripheral
nervous system (Mark et al. 1988; Shin et al. 1999;
Ichikawa et al. 2000; Ju et al. 2000; Lee et al. 2001;
Marsh et al. 2007). The neuronal phenotype of OPN
null mice has not been thoroughly examined, but
the lung, heart and kidney of mutant mice show
increased fibrosis and apoptosis (Ophascharoensuk
et al. 1999; Berman et al. 2004; Zohar et al. 2004).
The inner ear phenotype of the null mice has not
been examined either. In this study, we analyzed the
function of OPN in otoconia calcification utilizing
OPN knockout mice that are maintained as Spp1
(secreted phosphoprotein 1, the current official name
for OPN). Our working hypothesis is that otoconia
component proteins (collectively called otoconins)
regulate crystal growth and morphology. Establish-
ment of a mechanistic link between bone and
otoconia calcification will greatly benefit studies of
otoconia development and vestibular cell biology due
to the availability of a wealth of data on bone biology.
MATERIALS AND METHODS
Mice and histology
Osteopontin null (as OPNspp1) mice were obtained
from The Jackson Laboratory (Bar Harbor, ME, USA)
and maintained in the C57BL/6J (as C57) genetic
background by the supplier. Some experiments also
included the otoconia-deficient strain Otopetrin1tlt
(as Otop1tlt) that are known to show imbalance
behaviors (Ornitz et al. 1998; Jones et al. 2004; Zhao
et al. 2008). The Otop1tlt mice were also maintained in
the C57 genetic background by The Jackson Laboratory.
The mice were maintained by homozygous inbreeding
in the laboratory. Unless otherwise indicated, the
acronyms OPNspp1 and Otop1tlt refer to homozygous
mutants throughout the report. Animals were eutha-
nized by CO2 asphyxiation before tissue harvesting,
and all animal procedures were approved by the
Institutional Animal Care and Use Committee at the
Boys Town National Research Hospital in accordance
with federal guidelines.
For histological examination, inner ears were
dissected and fixed in paraformaldehyde (4%). After
decalcification in 0.1 M EDTA (pH 7.4) overnight,
tissues were embedded in paraffin for sectioning at
6 μm.
Alizarin red complexone staining
To visualize the degree of otoconia calcification, fixed
whole-mount vestibular tissues were stained with 1:50
dilutions [(in phosphate buffered saline (PBS)] of
0.5% alizarin red complexone (ARC; Sigma, St. Louis,
MO, USA), a reagent that stains calcium deposits, for
2 h or overnight at room temperature. After washing
off excess staining reagents, tissues were viewed using
a Zeiss LSM 510 confocal microscope.
Phalloidin staining
Fixed and decalcified vestibules were permeabilized
with 0.1% Triton X-100 in PBS for 30 min, washed
with PBS and stained with a 50 μg/ml FITC-conjugated
phalloidin solution (Sigma) for 40 min at room
temperature. Unbound conjugated phalloidin was
washed off with PBS, and tissues were viewed using a
Zeiss LSM 510 confocal microscope.
Scanning electron microscopy
Animals were anesthetized using a sublethal dose of
ketamine (167 mg/kg) and xylazine (2 mg/kg),
perfused through the left ventricle with artificial
endolymph (125 mM KCl, 25 mM KHCO3, 5 mM
HEPES, 2 mM CaCl2, 1 mM NaCl), followed by
20–30 ml 4% paraformaldehyde + 2.5% glutaralde-
hyde + 3 mM CaCl2 in 0.1 M sodium cacodylate
(pH 7.2). Utricles and saccules were dissected out of
the inner ear in the fixative, and openings were made
by gently breaking the bony capsules at the “roof” of
the utricle and saccule. Tissues were immersion-fixed
for 24 h in the same fixative, washed three times with
artificial endolymph, and postfixed in 1% osmium
tetroxide in 0.1 M sodium cacodylate (pH 7.2) for 1 h.
Samples were then dehydrated, critical point dried in
CO2, mounted, sputter coated with gold palladium,
and viewed on a Jeol (JSM-848) scanning electron
microscope (SEM) at 15 kV.
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Otoconia dissection and protein assays
A detailed description of crystal dissection and stringent
washes to clean off the filaments and membranes was
provided previously (Zhao et al. 2007). The crystals were
decalcified, and proteins were extracted with 10 μl of
buffer (40mMTris, 4%CHAPS (3-[(3-cholamidopropyl)
dimethylammonio]-1-propanesulfonate), 8 M urea,
10 mg/ml dithiothreitol (DTT), 0.15 M EDTA) at 4°C
overnight. The buffer was used to dissolve any EDTA-
insoluble component of otoconia crystals as was reported
for fish otoliths (Murayama et al. 2004). After removal of
EDTA and salts using a Centricon column (Millipore,
Billerica, MA, USA), protein concentrations and total
protein contents were determined using a Micro-
BCA (bicinchoninic acid) Protein Assay Kit (Pierce,
Rockford, IL, USA) following the manufacturer’s proto-
col. Briefly, 100 μl of each diluted bovine serum albumin
standards and protein samples were added into micro-
plate wells; 100 μl of freshly prepared working reagent
(A:B:C at 25:24:1) was added into each well and mixed
gently. The reaction was incubated at 37°C for 2 h with
rocking, and the absorbance wasmeasured at 562 nm on
a Quant MQX200 plate reader (Bio-Tek Instruments,
Inc. Winooski, VT, USA). Protein concentrations were
calculated according to standard curves.
Western blotting
Extraction of otoconial proteins and determination of
protein concentrations were carried out in the same way
as above. An aliquot of each sample containing an equal
amount of total protein was mixed with 2× sample
loading buffer (0.13MTris–HCl, 20%glycerol, 46mg/ml
sodium dodecyl sulfate (SDS), 0.2 mg/ml bromo-
phenol blue, 20 mg/ml DTT), boiled for 5 min, load-
ed onto a 4–15% gradient Tris–SDS gel (Bio-Rad,
Hercules, CA, USA), electrophoresed at 200 V in run-
ning buffer (25 mM Tris pH 8.3, 192 mM glycine, 0.1%
SDS) for 2 h, and transferred to a PVDF membrane
(Millipore) at 100 V for 1 h. The blot was washed once
with Tris buffer containing salt and Tween (TBST)
(50 mM Tris, 150 mM NaCl, 0.1% Tween-20) and treat-
ed with 3% blocking buffer (Roche Applied Science,
Indianapolis, IN, USA) overnight at room temperature.
The membrane was incubated with an antibody against
the N-terminal 15 amino acids of Oc90 (Zhao et al.
2007) at 1:1,000 dilution for 3 h followed by three
washes in TBST buffer and incubated with a peroxidase-
conjugated goat anti-rabbit IgG secondary antibody
(1:10,000; Sigma) for another 3 h. After three washes,
detection solution was added for 1 min, and the blot was
exposed to a Kodak X-ray film. Blots were imaged using
the Canoscan 8400F imaging station, and protein band
intensities were analyzed using the ImageJ software
(http://rsb.info.nih.gov/ij/).
Ratiometric calcium measurement
Otoconia crystals were dissected, and CaCO3 was
dissolved in 0.05 N HCl. Serial dilutions (150×–
200×) in Ca2+-free calibration buffer were made for
neutralization and quantification purposes and [Ca2+]
was measured using the ratiometric dye, Fura-2
(Molecular Probes, Eugene, OR, USA). After adding
Fura-2 (100 μM), an aliquot of test solution was placed
in a sealed glass pipette and imaged using a cooled
CCD camera (SensiCam, Cooke Corp., La Jolla, CA,
USA) on an upright fixed stage microscope (Nikon
E600FN, Garden City, NY, USA). Axon Imaging
Workbench (AIW 2.2, Axon Instruments) was used
to control the camera, filter wheel (Lambda 10–2,
Sutter Instruments, Novato, CA, USA), and image
acquisition. [Ca2+] was calculated from the ratio of
light emitted at 510 nm during alternate excitation by
340 and 380 nm light (Grynkiewicz et al. 1985).
Calibration constants (standard curve) were deter-
mined using a series of highly buffered Ca2+ test
solutions (Molecular Probes), and Ca2+ concentrations
in the resolved otoconia were determined using the
standard curve.
Tests for imbalance behaviors
The following complementary tests are commonly used
to detect balance deficits manifested in postural
control, spatial orientation, and sensorimotor function
and coordination (Trune and Lim 1983; Sondag et al.
1995, 1996, 1998, 1999; Ying et al. 1999; Jones et al.
2004; Walton et al. 2005; Rampello and Drago 1999;
Hamm 2001; Sajdel-Sulkowska et al. 2005). Severe
abnormalities in the gravity receptor organ often lead
to abnormal air-righting reflexes, irregular and wider
gaits, compromised ability to swim, or shortened stay
on the rotorod (Trune and Lim 1983; Ying et al. 1999;
Rampello and Drago 1999; Hamm 2001; Jones et al.
2004). Details of the methods are described in Zhao et
al. 2008 and are briefly summarized below. We assessed
the grip strengths of the animals to rule out neuro-
muscular weakness as a possible secondary outcome
of the vestibular sensory deficits. Furthermore, we
directly measured the input to the peripheral gravity
receptor organ using vestibular evoked potential
(VsEP) recordings. The age, genotype, and number
of mice tested are summarized in the corresponding
tables presented in the “Results” section.
The air-righting reflex was tested on pups three
times in a row on each day from P9 to P11. The
position with which the pups landed and the time
they took to right their body positions were recorded.
Reaching response was recorded by observing the
reaction of the limbs and head-bobbing behaviors
ZHAO ET AL.: Osteopontin and Otoconia 193
when animals were suspended by their tails. Animals
that extend their forelimbs and try to reach a surface
are normal, whereas animals with vestibular deficits
either clasp their forelimbs or have head-bobbing
behavior. Both adults (2–6 months old) and pups (2–
3 weeks old) were tested. Regularity of animals’ gaits was
observed on a white paper after applying India ink to the
paws. The stride length and width were compared be-
tween null and age-matched C57 controls using previ-
ously published methods (Klapdor et al. 1997; Clarke
and Still 1999) and adapted from a standard protocol
used by the Charles River Laboratories (Wilmington,MA,
USA). Findings with P20 pups are reported in this paper.
Swimming test
Swimming behavior of adult mice (2–6 months old)
was observed for 15–30 s. The test was repeated three
times on different days, and the following scoring
system was used: 0, the animal was totally submerged,
could not maintain orientation at the surface of the
water, and required immediate rescue. 1, the animal
could swim to the surface if submerged, but did not
maintain a horizontal body line at the surface and
may re-submerge briefly. 2, the animal stayed at the
surface but hesitated for a few seconds before
swimming almost normally. 3, the animal swam at
the surface immediately and maintained horizontal
body position at the surface. Due to some ambiguity
of scores 2 and 3, we categorized the mice as poor
(score 0), intermediate (score 1), or good swimmers
(score 2 and 3).
Rotorod test
Adult animals between the ages of 2–6 months old
were placed on a 2-cm-diameter stationary and then
on a rotating rod (Rotamex-5, Columbus Instruments,
Columbus, OH, USA). The rotation was initially set at
a constant speed of 5 rpm/min as a test run. Once
each mouse was able to maintain balance for 1 min in
each trial, it was then tested on the accelerating rod
(5–20 rpm over 3 min) for three consecutive trials per
day for four consecutive days. At the end of each trial,
animals that stayed on the rod were left on until they
fell. A laser sensor detected if the animal fell from the
rod, and the time and speed of rotation at falling were
recorded. The average time the mice remained on
the rotorod (mean latency) was calculated from five
to eight animals and plotted for each trial, each
genotype, and each age group. The mean values of all
mice in one genotype were compared with those of
C57 controls in the same trial using Student’s t test
assuming similar variances. All tests were carried out
within the same time window of the day (between 2
and 4 P.M.) to control for possible variations intro-
duced by circadian rhythms.
Beam-crossing
A round wood bar of 2.5 cm in diameter was attached
to two Styrofoam platforms at the ends, and the
length of the bar to be crossed is adjustable at the
ends. Before the test, adult mice (2–6 months old)
were fasted for a maximum of 4 h (water was provided
ad libitum) to use food (rodent chow) as an effective
incentive for the animals to cross the beam. Pretrain-
ing of mice on the bar at 5 cm long was performed
first, followed by three trials of crossing the bar at
30 cm long in a row. As wild-type (wt) mice often
paused on the beam to explore at some point, time
spent in crossing the bar at 30 cm was not used for
quantitative purposes. Rather, the posture (i.e., low-
ered body position) and behavior (i.e., reluctance,
nervousness) on the beam were observed.
Grip-strength test
Mutant and control mice were made to hang in a
supine position on an inverted metal meshwork, and
the length of time the animal remained on the
meshwork was recorded.
Data analysis
Data are presented as mean±standard deviation
(SD) where applicable. Balance behaviors (except
rotorod tests) of mutant strains were compared to C57
controls using Chi-square analysis. Latencies before
falling off the rotorod were compared as described
above. P values less than 0.05 were considered
statistically significant.
Measurement of vestibular-evoked potentials
Animal preparation
The use of animals for vestibular-evoked potentials
(VsEPs) was also approved at East Carolina University.
Mice were anesthetized with a ketamine (120 mg/kg)
and xylazine (13 mg/kg) solution, and core body
temperature was maintained at 37.0±0.1°C using a
homeothermic heating blanket system (FHC, Inc.).
VsEPs were measured from 5-month-old mice.
Vestibular stimulus coupling and recording parameters
VsEP recording procedures followed methods previ-
ously published (Jones et al. 1999, 2002, 2004; Jones
and Jones 1999). Herein, we used a noninvasive
method (a spring clip) to couple the head to the
voltage-controlled mechanical shaker that delivered
the motion stimuli. Linear acceleration pulses (17
pulses/s, 2 ms duration) were presented to the
cranium in the naso-occipital axis using two stimulus
polarities, normal and inverted. Stimulus amplitude
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ranged from +6 dB to −18 dB re: 1.0 g/ms (where 1 g=
9.8 m/s2) adjusted in 3 dB steps.
Ongoing electroencephalographic activity was am-
plified (200,000×), filtered (300 to 3,000 Hz, −6 dB
amplitude points), and digitized (1,024 points, 10 μs/pt).
Primary responses, 256, were averaged and replicated for
each VsEP waveform. VsEP recordings began at the
maximum stimulus intensity (i.e., +6 dB re: 1.0 g/ms)
with and without acoustic masking (broadband forward
masker 50 to 50,000 Hz at 97 dB SPL), then intensity was
dropped to −18 dB and raised in 3 dB steps to complete
an intensity profile. The masker was used to verify
absence of cochlear responses (Jones and Jones 1999).
Data analysis
The first positive and negative response peaks were
scored for VsEPs, as this initial response peak is
generated by the peripheral eighth nerve. Peak
latencies (measured in milliseconds, ms), peak-
to-peak amplitude (measured in microvolts, μV) and
thresholds (measured in dB re: 1.0 g/ms) were
quantified. Descriptive statistics were generated, and
independent sample t test was used to compare VsEP
response parameters between OPNspp1 and C57 mice.
RESULTS
Osteopontin is not required for otoconia
formation
The similar effects of Oc90 and OPN on crystal
formation suggest that OPN may regulate otoconia
calcification. In the present study, we tested this
hypothesis by analyzing the otoconia phenotype of
the OPNspp1 null mice. Deletion of OPN protein in
the null mice was previously validated (Liaw et al.
1998) and was confirmed in the present study by
Western blotting of otoconia extracts (data not
shown). With Oc90 comprising nearly 90% of the
otoconial protein content (Pote and Ross 1986; Wang
et al. 1998; Ornitz et al. 1998), OPN is present at only
a low level in wt otoconia (Takemura et al. 1994;
Sakagami 2000; Zhao et al. 2007).
No abnormality was found in the overall appear-
ance of the end organ of the OPNspp1 null mice.
Shown in Figure 1 is hematoxylin-and-eosin (H&E)-
stained 6 μm sections of the utricule and saccule. All
structures, including hair/supporting cells and the
otoconia layer, were apparently normal. SEM obser-
vation of otoconia crystals revealed normal sizes and
morphology when compared to those of C57 mice
(Fig. 2A, B and Table 1). Averaged measurements of
lengths and midsection widths are shown in Table 1.
There was no significant difference in the averaged
measurements of lengths×widths of otoconia crystals
in representative areas sampled in C57 and OPNspp1
mice: above the peripheral utricular macula, above
the central utricular macula, and all over the saccule.
Similar to those in C57 mice, the saccular otoconia of
the OPNspp1 mice were more homogeneous in sizes
and were much smaller than the utricular ones. The
ratio of length versus width was about 2:1 for both
utricular and saccular crystals in both strains of mice.
Unlike the Oc90 null mice (Zhao et al. 2007), there
was no reduction in the otoconial membranes (OM)
of the OPNspp1 utricle and saccule (Fig. 2C, D). In
Figure 2C and D, the whole-mount tissues were
partially decalcified to expose some parts of the OM
for observation and at the same time to leave some
overlying crystals to minimize mechanic tearing of the
OM. Only the OM of the striola region is shown in the
figure. OM in the peripheral region of the utricle and
saccule of the OPNspp1 vestibule has smaller holes
than the striola region, similar to those in C57 (data
not shown). Staining of inorganic CaCO3 deposits
with ARC showed similar degrees of otoconia calcifi-
cation in the OPNspp1 and C57 mice (Fig. 2E, F),
which was confirmed by fura-2 ratiometric Ca2+
measurements of equal masses (0.24 mg) of otoconia
dissolved in equal volumes of 0.05 N HCl (10 μl each;
Fig. 3A). In Figure 3A, the Ca2+ concentrations were
similar between OPNspp1 and C57 mice (p=0.4).
FIG. 1. No abnormality is found in the morphology of the otoconia
layer and the vestibule of OPNspp1 mice. H&E-stained paraffin-
embedded sections (6 μm) are shown. The OPNspp1 otoconia layer has
normal thickness and staining pattern forH&E (B&D) as compared to
that in the C57 control (A&C). G Gelatinous layer, O otoconia, OM
otoconial membrane, M macula (including hair/supporting cells).
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To identify potential compensatory events, if any,
that may have led to the normal otoconia phenotype,
we analyzed the total protein content and composi-
tion of OPNspp1 null otoconia (1 month old). The
null crystals contained 4.5±0.52 μg total protein/mg
otoconia mass, compared to 4.2±0.65 μg total pro-
tein/mg otoconia mass for age-matched C57 otoconia
(p=0.40, n=4) (Fig. 3A). Western blotting of protein
extracts from OPNspp1 and C57 otoconia showed
similar levels of Oc90 (Fig. 3B; p90.05). The p value
was obtained by the Student’s t test of the products of
the intensity (pixels)×area of Oc90 bands of null and
control blots. The small difference in the total protein
loaded in the gel (3.9 μg for C57 and 4.2 μg for
OPNspp1) was taken into account in the calculation.
The migratory property of Oc90 was also unaltered in
the null mice, suggesting normal posttranslational
modification. The unmodified theoretical mass of
secreted murine Oc90 is 50 kDa, and the size of the
predominant glycosylated form is approximately
80 kDa (Ignatova et al. 2004; Zhao et al. 2007). These
unchanged measurements exclude significant deposi-
tion of ectopic compensatory proteins that are
normally foreign to otoconia. Although the data do
not directly exclude possible deposition of another
compensatory minor protein, the increased mineral
content in bone crystals of OPN nulls argues against
such a possibility (Boskey et al. 1993; Hunter et al.
1994; Shapses et al. 2003). Thus, OPN is not likely to
play a significant role in otoconia morphogenesis or
calcification. It is possible that the protein may not be
an integral part of otoconia but only adheres to the
crystals, which is also suggested by its presence in
Oc90 null otoconia that lack any organic matrix
(Zhao et al. 2007).
Osteopontin is not critical for the morphogenesis
or function of the gravity receptor organ
Next, we examined the vestibular morphology and
ultrastructure of OPNspp1 null mice to gain insight
into the role of the protein in vestibular development
and function. In addition to the normal utricular and
saccular structures shown in Figure 1, the density and
organization of hair cells and stereocilia were similar
between the null and C57 utricle and saccule, as
visualized by phalloidin-staining of hair bundles in
decalcified whole-mount tissues (Fig. 4). High magni-
fication SEM showed no abnormality in hair bundle
sizes or organization in the OPNspp1 vestibule (insets
in Fig. 4). Thus, absence of OPN does not affect the
morphological development of the gravity receptor
organ.
Given the expression patterns of OPN in vestibular
hair cells and other nervous tissues, the OPNspp1 mice
FIG. 2. A, B OPNspp1 otoconia have normal morphology and sizes
as demonstrated by SEM. Detailed size measurements are presented
in Table 1. The inset provides a closer view of the peripheral crystals
in (B). The scale bar in the inset is also 10 μm. C, D SEM of partially
decalcified tissues shows normal otoconia membrane in the OPNspp1
null utricle and saccule (the utricle is shown). E, F Normal degree of
otoconia calcification in the OPNspp1 null mice as demonstrated by
staining of inorganic calcium deposits with Alizarin Red Complex-
one. Quantitative ratiometric Ca2+ measurements are presented in
Figure 3.
TABLE 1
Normal sizes of OPNspp1 otoconia compared to those of C57
mice (6-month-old animals sampled, n=16)
Genotype Length (μm) Width (μm)
Peripheral utricle C57 14.5±2.8 7.3±1.6
OPNspp1 13.0±2.1 7.3±1.0
Central utricle C57 4.2±1.0 2.6±0.3
OPNspp1 4.3±0.7 2.4±0.3
Saccule C57 2.0±0.3 1.1±0.1
OPNspp1 1.8±0.4 1.0±0.1
There are no significant differences in the lengths×widths of C57 and
OPNspp1 utricular or saccular otoconia
OPN Osteopontin
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may have molecular deficits in the sensory cells,
ganglia, or other nervous tissues despite the unaffect-
ed morphology. Such deficits may lead to imbalance
of the animals. We performed a series of balance tests
to test this hypothesis. Several issues may make it
difficult to pinpoint the source of balance deficits, if
any, in the null mice. First of all, behavioral tests assess
coordinated functions of the peripheral and central
nervous systems (PNS and CNS) and the neuromus-
cular system. Potential effects, if any, of OPN deletion
on the nervous system are likely diverse, with both
beneficial and adverse outcomes (see “Discussion”
section for more details). In addition, mild deficits
may elude detection due to behavioral adaptation.
Nevertheless, when interpreted with other types of
data including reports of CNS and PNS analyses of the
mice, the wide spectrum of balance tests performed
on a number of mice should provide an indication of
vestibular function despite the limitation of each test
alone.
OPNspp1 null pups showed normal development of
the air-righting reflex (Table 2). Between P9–11, null
mice, like their C57 controls, could instantly right
their body positions (G0.8 s on average at P9) and
land in an upright position when held by their tails
and suspended to make a backward somersault. In
comparison, 91–100% of Otop1tlt mice often landed
in a supine position rather than the normal prone
position and took 93 s on average to right their body
positions. All the OPNspp1 null pups and adults had
normal reaching responses (Table 2), posture, and
gaits (Fig. 5A, B). The mice manifested no unusual
home cage behavior, nor did they circle, tilt their
heads, move slowly, or become confused. All the
OPNspp1 mice swam normally (score 3; Table 2) and
crossed the beam just like the controls. The mice had
normal grip strengths as well, indicating an absence of
neuromuscular weakness.
In addition, the OPNspp1 mice performed well on
the rotorod (Fig. 5C): The latencies of their stay on
the accelerating rotorod had no significant differ-
ences compared to those for age-matched C57 con-
trols on all days (day 1–4; p90.05, 2–6 months old). In
contrast, age-matched Otop1tlt mice stayed on two to
three times shorter than either C57 mice or OPNspp1
(pG0.05; Zhao et al. 2008). Like the C57 mice, the
OPNspp1 mice demonstrated remarkable learned
behavioral adaptation of vestibular functions and
stayed longer with the progressing of each trial. There
was a nearly fourfold increase in latencies on the
rotorod on day 4 compared to day 1 (pG0.001),
demonstrating normal synaptic potentiation of vestib-
ular neurons, proprioceptors, or locomotor control
centers. Although central compensation can poten-
tially mask peripheral deficits (Rampello and Drago
1999; Dubois et al. 2002; Besson et al. 2005; Bothe et
al. 2005), concurrent tests with otoconia mutants show
that the learned improvement actually differentiates
further the normal and imbalance behaviors because
the mutants improved less after training (Zhao et al.
FIG. 4. No abnormality is found in the density, organization, and
appearance of stereocilia in the adult vestibule of OPNspp1 null mice.
Phalloidin-stainedwhole-mount utricles of OPNspp1 (B) and C57 mice
(A) and SEM of utricular hair bundles (insets) are shown. Arrows
indicate orientation of whole-mount tissues (A Anterior, L lateral).
FIG. 3. A The total protein content and calcium concentration are
similar between C57 and OPNspp1 null otoconia (p90.05, n=4; p9
0.05, n=8 respectively). The calcium concentrations are compared
with equal volume (10 μl) and equal mass (0.24 mg) of dissolved
otoconia. B The level of the predominant otoconial protein, Oc90, is
similar in equal masses of C57 and OPNspp1 null otoconia. Analysis
of protein band intensities×areas showed no significant difference
between C57 and OPNspp1.
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2008). Furthermore, the normal balance behaviors
are consistent with the normal morphology and
ultrastructure of otoconia and vestibular sensory
epithelia. Therefore, OPN is not critical for balance
functions.
To confirm the conclusion from behavioral assess-
ments, we directly measured the afferent function of
the gravity receptor organ under the stimuli of linear
motion. Figure 6A shows VsEP thresholds for OPNspp1
null and C57 control mice. On average, OPNspp1 mice
had VsEP thresholds similar to the controls (−9.5±
3.1 dB re: 1.0 g/ms for OPNspp1, −9.7±2.1 dB re:
1.0 g/ms for C57). VsEP response peak amplitudes
(data not shown) and latencies (Fig. 6B) were also
similar between the two strains of mice. Therefore,
absence of OPN does not alter the sensory input or
the functional status of the gravity receptor organ.
DISCUSSION
Despite the prevalence of otoconia-related balance
problems in humans, the underlying molecular etiol-
ogy is completely unknown. In recent years, a number
of otoconins have been identified, but the roles of
most of these proteins in crystal formation remain
unclear. Dissecting the importance of each otoconial
protein in otoconia development will help in design-
ing rational treatments for otoconial lesion and for
prevention and regeneration purposes.
The absence of any changes in the ultrastructure,
protein and calcium content of OPNspp1 null otoconia
strongly suggests that the protein is not critical for
otoconia formation and that compensation by anoth-
er unidentified factor is unlikely. The normal balance
behaviors, morphology and ultrastructure of the null
utricle and saccule indicate that the protein is also not
FIG. 5. Normal balance behaviors of OPNspp1 null mice. Statistical
comparisons are listed in Table 2. OPNspp1 null mice have normal
gaits B compared to C57Bl/6 mice A. C The latencies on the
accelerating rod are similar for OPNspp1 null mice (n=8) and age-
matched C57 mice (n=5, 2–6 months old). Error bars represent SDs.
TABLE 2
OPNspp1 null mice show normal balance behaviors
Abnormal/total C57 Otop1tlt OPNspp1
Head-tilting (2–3 weeks) 0/12 10/12* 0/11
Head-tilting (adult) 0/12 7/10* 0/8
Air-righting (P9–10) 0/10 9/9* 0/8
Reaching (2–3 weeks) 0/10 12/12* 0/11
Reaching (adult) 0/12 7/10* 0/8
Swimming (adult) 0/14 6/8* 0/8
The number of mice showing imbalance behaviors is shown as numerators
and the total number of mice tested as denominators. The Otop1tlt mice are
known to have imbalance behaviors (Ornitz et al. 1998; Jones et al. 2004;
Zhao et al. 2008) and are included here as a comparison. Adult ages tested
were 2–6 months old. Poor and intermediate swimmers were counted as
abnormal.
Otop1 Otopetrin 1, OPN osteopontin
*Denotes significant difference (pG0.05) compared to C57 balance behav-
iors using Chi-square analysis
FIG. 6. A Similar VsEP thresholds for OPNspp1 null (as Spp1) and
C57 control mice. Solid horizontal lines represent the mean for each
group and the dashed lines represent 1 SD above and below the
mean. BMean VsEP latencies for response peak P1 (generated by the
peripheral vestibular nerve) as a function of stimulus amplitude. Error
bars represent SDs. On average, response peak latencies for OPNspp1
mice are similar to controls.
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critical for the morphogenesis or function of the
gravity receptor organ, which is confirmed by the
presence of normal VsEPs.
Both Oc90 and OPN are non-collagenous matrix
proteins that, together with collagen, form the
organic framework upon which the inorganic crystals
are deposited (Rana-Chavez and Nanci 2001; Laboux
et al. 2003; Zhao et al. 2007). Both limit the growth of
the mineral crystals, but neither is involved in the
initial mineral accretion (Shapses et al. 2003; Zhao et
al. 2007). The effect of OPN on bone mineral
deposition is a combination of a direct involvement
of the protein as a hydroxyapatite-binding matrix
protein and as a signaling molecule that recruits
osteoclasts (Shapses et al. 2003). Oc90 is required to
form the otoconia matrix by specifically recruiting
other matrix components (Zhao et al. 2007). It has
not been examined whether Oc90 has other indirect
effects on otoconia formation.
Interestingly, OPN and Oc90 are co-expressed in
vestibular dark cells and the endolymphatic sac, with
the onset of Oc90 expression being much earlier than
that for OPN (Verpy et al. 1999; Sakagami 2000;
Ignatova et al. 2004). Given the negligible role of OPN
in otoconia formation, such cellular co-localization may
be coincidental or may merely reflect cellular activities in
secretion and/or ion fluxes, two processes that may
provide some components for otoconia formation or
maintain homeostasis of the endolymph. A calcium
pump, plasma membrane-bound calcium ATPase
(PMCA2), is also expressed in dark cells, in addition to
hair cells, and mice with mutant PMCA2 have absent
otoconia (Kozel et al. 1998). Unlike the bone environ-
ment, Ca2+ concentration in the endolymph is low.
The Ca2+-binding otoconial proteins and sulfated
GAGs may be co-secreted with Ca2+ or may sequester
Ca2+ and efficiently raise the local Ca2+ level in the
matrix and/or in the otoconial membranes for
calcification. As the functions of these molecules in
Ca2+-sequestration may be redundant, it is possible
that deletion of a minor component like OPN is
buffered by other multiple components without the
need to increase their expression levels.
It is not clear what kind of effect OPN may have on
sensorimotor neurons. The potential impact (if any)
of OPN on the CNS and PNS to affect balance and
coordination likely involve both positive and negative
effects. At the cellular level, the protein has pro-
adhesive, chemotactic and cytokine-like properties,
and is involved in a number of physiologic and
pathologic events including angiogenesis, apoptosis,
inflammation, oxidative stress, remyelination, wound
healing, bone remodeling, cell migration and tumor-
igenesis (Chakraborty et al. 2006; El-Tanani et al.
2006; Pagano and Haurani 2006). As some of these
events lead to neurodegeneration (Maetzler et al.
2007; Wung et al. 2007) whereas others to neuro-
protection (Meller et al. 2005; Schroeter et al. 2006),
the overall outcome in sensorimotor neurons may
have been neutralized in the null deletion.
In summary, we demonstrate that OPN is not
critical for otoconia formation or balance functions.
When interpreted with previous findings, the data
show a hierarchy of importance of otoconins in
crystallization. Given the critical role of OPN in bone
crystal growth, the present study indicates molecular
differences between otoconia and bone calcification.
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